Further understanding of tau phosphorylation: implications for therapy
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Further understanding of tau phosphorylation: implications for therapy
Authors
Keywords
-
Journal
Expert Review of Neurotherapeutics
Volume 15, Issue 1, Pages 115-122
Publisher
Informa UK Limited
Online
2015-01-03
DOI
10.1586/14737175.2015.1000864
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Chaperone-like Antibodies Targeting Misfolded Tau Protein: New Vistas in the Immunotherapy of Neurodegenerative Foldopathies
- (2017) Norbert Zilka et al. JOURNAL OF ALZHEIMERS DISEASE
- New perspectives on the role of tau in Alzheimer's disease. Implications for therapy
- (2014) Miguel Medina et al. BIOCHEMICAL PHARMACOLOGY
- A phase 2 trial of the GSK-3 inhibitor tideglusib in progressive supranuclear palsy
- (2014) Eduardo Tolosa et al. MOVEMENT DISORDERS
- Tideglusib reduces progression of brain atrophy in progressive supranuclear palsy in a randomized trial
- (2014) Günter U. Höglinger et al. MOVEMENT DISORDERS
- The influence of phospho-tau on dendritic spines of cortical pyramidal neurons in patients with Alzheimer’s disease
- (2013) Paula Merino-Serrais et al. BRAIN
- Physiological release of endogenous tau is stimulated by neuronal activity
- (2013) Amy M Pooler et al. EMBO REPORTS
- Repeated immunization of mice with phosphorylated-tau peptides causes neuroinflammation
- (2013) Lea Rozenstein-Tsalkovich et al. EXPERIMENTAL NEUROLOGY
- New insights into the role of glycogen synthase kinase-3 in Alzheimer's disease
- (2013) Miguel Medina et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- Diaminothiazoles Modify Tau Phosphorylation and Improve the Tauopathy in Mouse Models
- (2013) Xuemei Zhang et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Leucine Carboxyl Methyltransferase 1 (LCMT1)-dependent Methylation Regulates the Association of Protein Phosphatase 2A and Tau Protein with Plasma Membrane Microdomains in Neuroblastoma Cells
- (2013) Jean-Marie Sontag et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tau pathology and neurodegeneration
- (2013) Maria Grazia Spillantini et al. LANCET NEUROLOGY
- Efficacy and Safety of A Liposome-Based Vaccine against Protein Tau, Assessed in Tau.P301L Mice That Model Tauopathy
- (2013) Clara Theunis et al. PLoS One
- The Importance of Tau Phosphorylation for Neurodegenerative Diseases
- (2013) Wendy Noble et al. Frontiers in Neurology
- Targeting Phospho-Ser422 by Active Tau Immunotherapy in the THYTau22 Mouse Model: A Suitable Therapeutic Approach
- (2012) Nadege Zommer et al. Current Alzheimer Research
- Glycogen Synthase Kinase-3 (GSK-3) Inhibitors for the Treatment of Alzheimers Disease
- (2012) Miguel Medina et al. CURRENT PHARMACEUTICAL DESIGN
- Constitutive secretion of tau protein by an unconventional mechanism
- (2012) Xiyun Chai et al. NEUROBIOLOGY OF DISEASE
- Tau Overexpression Results in Its Secretion via Membrane Vesicles
- (2012) Diana Simón et al. Neurodegenerative Diseases
- Tau elevations in the brain extracellular space correlate with reduced amyloid-β levels and predict adverse clinical outcomes after severe traumatic brain injury
- (2011) Sandra Magnoni et al. BRAIN
- Disease-modifying properties of long-term lithium treatment for amnestic mild cognitive impairment: randomised controlled trial
- (2011) Orestes V. Forlenza et al. BRITISH JOURNAL OF PSYCHIATRY
- Proteostasis of tau. Tau overexpression results in its secretion via membrane vesicles
- (2011) Diana Simón et al. FEBS LETTERS
- Evidence for Irreversible Inhibition of Glycogen Synthase Kinase-3β by Tideglusib
- (2011) Juan Manuel Domínguez et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Exosome-associated Tau Is Secreted in Tauopathy Models and Is Selectively Phosphorylated in Cerebrospinal Fluid in Early Alzheimer Disease
- (2011) Sudad Saman et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tau splicing and the intricacies of dementia
- (2011) Athena Andreadis JOURNAL OF CELLULAR PHYSIOLOGY
- Passive immunization targeting pathological phospho-tau protein in a mouse model reduces functional decline and clears tau aggregates from the brain
- (2011) Allal Boutajangout et al. JOURNAL OF NEUROCHEMISTRY
- In Vivo Microdialysis Reveals Age-Dependent Decrease of Brain Interstitial Fluid Tau Levels in P301S Human Tau Transgenic Mice
- (2011) K. Yamada et al. JOURNAL OF NEUROSCIENCE
- The Many Faces of Tau
- (2011) Meaghan Morris et al. NEURON
- Molecular Implication of PP2A and Pin1 in the Alzheimer's Disease Specific Hyperphosphorylation of Tau
- (2011) Isabelle Landrieu et al. PLoS One
- Genome-Wide Association Study Confirms SNPs inSNCAand theMAPTRegion as Common Risk Factors for Parkinson Disease
- (2010) Todd L. Edwards et al. ANNALS OF HUMAN GENETICS
- Alzheimer's disease neurofibrillary degeneration: pivotal and multifactorial: Figure 1
- (2010) Khalid Iqbal et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Functional implications of the association of tau with the plasma membrane
- (2010) Amy M. Pooler et al. BIOCHEMICAL SOCIETY TRANSACTIONS
- Efficacy and safety of immunization with phosphorylated tau against neurofibrillary tangles in mice
- (2010) Moran Boimel et al. EXPERIMENTAL NEUROLOGY
- The carboxy-terminal fragment of inhibitor-2 of protein phosphatase-2A induces Alzheimer disease pathology and cognitive impairment
- (2010) Xiaochuan Wang et al. FASEB JOURNAL
- Nuclear Tau, a Key Player in Neuronal DNA Protection
- (2010) Audrey Sultan et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Regulation of protein phosphatase 2A methylation by LCMT1 and PME-1 plays a critical role in differentiation of neuroblastoma cells
- (2010) Jean-Marie Sontag et al. JOURNAL OF NEUROCHEMISTRY
- Immunotherapy Targeting Pathological Tau Prevents Cognitive Decline in a New Tangle Mouse Model
- (2010) A. Boutajangout et al. JOURNAL OF NEUROSCIENCE
- Can Alzheimer disease be prevented by amyloid-β immunotherapy?
- (2010) Cynthia A. Lemere et al. Nature Reviews Neurology
- Chaperone-Like Antibodies in Neurodegenerative Tauopathies: Implication for Immunotherapy
- (2009) Eva Kontsekova et al. CELLULAR AND MOLECULAR NEUROBIOLOGY
- Propagation of Tau Misfolding from the Outside to the Inside of a Cell
- (2009) Bess Frost et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tangle-Bearing Neurons Survive Despite Disruption of Membrane Integrity in a Mouse Model of Tauopathy
- (2009) Alix de Calignon et al. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
- Monitoring of brain interstitial total tau and beta amyloid proteins by microdialysis in patients with traumatic brain injury
- (2009) Niklas Marklund et al. JOURNAL OF NEUROSURGERY
- Transmission and spreading of tauopathy in transgenic mouse brain
- (2009) Florence Clavaguera et al. NATURE CELL BIOLOGY
- Genome-wide association study reveals genetic risk underlying Parkinson's disease
- (2009) Javier Simón-Sánchez et al. NATURE GENETICS
- Tau phosphorylation: the therapeutic challenge for neurodegenerative disease
- (2009) Diane P. Hanger et al. TRENDS IN MOLECULAR MEDICINE
- The tau code
- (2009) Jesus Avila Frontiers in Aging Neuroscience
- Hyperphosphorylation of Microtubule-Associated Protein Tau: A Promising Therapeutic Target for Alzheimer Disease
- (2008) C.-X. Gong et al. CURRENT MEDICINAL CHEMISTRY
- I PP2A 1 Affects Tau Phosphorylation via Association with the Catalytic Subunit of Protein Phosphatase 2A
- (2008) She Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Tau-based treatment strategies in neurodegenerative diseases
- (2008) Anja Schneider et al. Neurotherapeutics
- Differential Regulation of Dynein and Kinesin Motor Proteins by Tau
- (2008) R. Dixit et al. SCIENCE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started